Third Security, Transgenomic enter Convertible Promissory Note Purchase Agreement

NewsGuard 100/100 Score

Transgenomic, Inc. (OTCBB: TBIO) today announced that it has entered into a Convertible Promissory Note Purchase Agreement (the "Purchase Agreement") in the aggregate amount of $3.0 million with entities (the "Investors") associated with Third Security, LLC, a leading life sciences investment firm.

"We are very pleased with the additional investment by Third Security affiliates as it increases our working capital and allows us to continue our expansion plan," said Craig Tuttle, President and Chief Executive Officer of the Company.

Source: Transgenomic

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.